199 related articles for article (PubMed ID: 18196642)
21. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Bułdak Ł; Duława A; Krysiak R; Okopień B
Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
[TBL] [Abstract][Full Text] [Related]
22. Other important applications for beta-blockers in high-risk patients.
Egan BM; Chilton RJ
Postgrad Med; 2003 Dec; 114(6 Suppl Role):35-48. PubMed ID: 19667668
[TBL] [Abstract][Full Text] [Related]
23. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study.
Liou YS; Ma T; Tien L; Lin CM; Jong GP
Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541
[TBL] [Abstract][Full Text] [Related]
24. Will β-blockers live up to the maxim of Sir James Black, their creator?
Al-Waili K; Al-Rasadi K; Banerjee Y
Angiology; 2012 Aug; 63(6):409-11. PubMed ID: 22718079
[No Abstract] [Full Text] [Related]
25. beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain.
Yalcin I; Choucair-Jaafar N; Benbouzid M; Tessier LH; Muller A; Hein L; Freund-Mercier MJ; Barrot M
Ann Neurol; 2009 Feb; 65(2):218-25. PubMed ID: 19259968
[TBL] [Abstract][Full Text] [Related]
26. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
27. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.
Topiol S; Sabio M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1598-602. PubMed ID: 18243704
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiological basis of migraine prophylaxis.
Galletti F; Cupini LM; Corbelli I; Calabresi P; Sarchielli P
Prog Neurobiol; 2009 Oct; 89(2):176-92. PubMed ID: 19654035
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics of therapy with blockers of beta-adrenergic receptors].
Szám I
Lijec Vjesn; 1984; 106(11-12):490-3. PubMed ID: 6151616
[No Abstract] [Full Text] [Related]
30. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
31. [Blockers of beta-adrenergic receptors--a group of chiral agents stereoselective synthesis of beta-blockers].
Cizmáriková R; Valentová J; Hutt AJ; Sedláková S
Ceska Slov Farm; 2005 Sep; 54(5):201-6. PubMed ID: 16209433
[TBL] [Abstract][Full Text] [Related]
32. Challenges for beta-blockers as first-line therapy for elderly hypertensive patients.
Prisant LM
Postgrad Med; 2002 Dec; 112(6 Suppl Heart):34-41. PubMed ID: 19667616
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
Messerli FH; Bangalore S; Yao SS; Steinberg JS
J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacology of beta blockers].
Kazić T
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():5-9. PubMed ID: 18193805
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic potential of third-generation beta-adrenergic receptor blockers. Satellite symposium to the Xth Congress of the European Society of Cardiology. Vienna, Austria, August 31, 1988.
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S1-44. PubMed ID: 2481784
[No Abstract] [Full Text] [Related]
38. Exercise-induced improvement in atrial depolarization abnormality in a patient after treatment with beta-adrenergic blockers.
Ariyarajah V; Shaikh N; Spodick DH
Cardiology; 2008; 111(1):36-40. PubMed ID: 18239390
[TBL] [Abstract][Full Text] [Related]
39. From adrenoceptor mechanisms to clinical therapeutics: Raymond Ahlquist, Ph.D., 1914-1983.
Wenger NK; Greenbaum LM
J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):419-21. PubMed ID: 6141195
[TBL] [Abstract][Full Text] [Related]
40. Beta-blockers for treatment of hypertension.
Basile JN; Cohen JD
Postgrad Med; 2003 Dec; 114(6 Suppl Role):11-7. PubMed ID: 19667665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
